Danielson L A, Conrad K P
Department of Physiology, University of New Mexico School of Medicine, Albuquerque 87131, USA.
J Clin Invest. 1995 Jul;96(1):482-90. doi: 10.1172/JCI118059.
Because the kidneys are vasodilated and the endogenous production of nitric oxide is increased in gravid rats, we tested whether nitric oxide mediates the renal vasodilatory response to pregnancy. Chronically instrumented, conscious rats of gestational days 12-14 were studied concurrently with age-matched virgin control animals. GFR and effective renal plasma flow (ERPF) were determined by the renal clearances of inulin and para-aminohippurate before and during acute infusion of N omega-nitro-L-arginine methyl ester (NAME; 2, 20, and 50 micrograms/min) or NG-monomethyl-L-arginine (100 micrograms/min). Baseline GFR and ERPF were significantly increased, and effective renal vascular resistance was decreased by 30-40% in gravid rats compared with virgin controls. During infusion of all three dosages of NAME and NG-monomethyl-L-arginine, effective renal vascular resistance, GFR, and ERPF were equalized in the pregnant and virgin rats (the only exception being GFR during the 20 micrograms/min NAME infusion). When compared with virgin rats, the gravid animals were more responsive to nitric oxide synthase inhibition, showing a significantly greater decline in GFR and ERPF and rise in effective renal vascular resistance at each timepoint during the infusion of inhibitor. To exclude the possibility that nonspecific renal vasoconstriction per se led to equalization of renal function in the two groups of rats, we investigated angiotensin II. In contrast to the results observed with nitric oxide synthase inhibitors, pregnant rats were less responsive to the renal vasoconstrictory effects of angiotensin II, such that the baseline differences in renal parameters measured before infusion of the hormone were increased during the infusion. To determine whether nitric oxide synthase was inhibited to a similar extent in gravid and virgin rats, aortic and renal cortical cGMP content was assayed ex vivo at the end of inhibitor infusion. The lower 2-micrograms/min dose of NAME consistently reduced cGMP content of these tissues to comparable levels in the two groups of rats. In conclusion, we suggest that nitric oxide mediates reduced renal vascular resistance and hyperfiltration during pregnancy in conscious rats.
由于妊娠大鼠的肾脏血管舒张,内源性一氧化氮生成增加,我们测试了一氧化氮是否介导了妊娠时的肾血管舒张反应。对妊娠第12 - 14天长期植入仪器的清醒大鼠与年龄匹配的未孕对照动物同时进行研究。在急性输注Nω-硝基-L-精氨酸甲酯(NAME;2、20和50微克/分钟)或NG-单甲基-L-精氨酸(100微克/分钟)之前和期间,通过菊粉和对氨基马尿酸的肾清除率测定肾小球滤过率(GFR)和有效肾血浆流量(ERPF)。与未孕对照相比,妊娠大鼠的基线GFR和ERPF显著增加,有效肾血管阻力降低30 - 40%。在输注所有三种剂量的NAME和NG-单甲基-L-精氨酸期间,妊娠和未孕大鼠的有效肾血管阻力、GFR和ERPF达到平衡(唯一的例外是在输注20微克/分钟NAME期间的GFR)。与未孕大鼠相比,妊娠动物对一氧化氮合酶抑制更敏感,在输注抑制剂期间的每个时间点,GFR和ERPF下降幅度更大,有效肾血管阻力上升幅度更大。为排除非特异性肾血管收缩本身导致两组大鼠肾功能平衡的可能性,我们研究了血管紧张素II。与一氧化氮合酶抑制剂的结果相反,妊娠大鼠对血管紧张素II的肾血管收缩作用反应较小,以至于在输注该激素之前测量的肾参数的基线差异在输注期间增大。为确定妊娠和未孕大鼠中一氧化氮合酶是否受到相似程度的抑制,在抑制剂输注结束时离体测定主动脉和肾皮质的环磷酸鸟苷(cGMP)含量。较低剂量2微克/分钟的NAME持续将两组大鼠这些组织的cGMP含量降低至相当水平。总之,我们认为一氧化氮介导了清醒大鼠妊娠期间肾血管阻力降低和超滤增加。